- Home
- A-Z Publications
- Current Diabetes Reviews
- Previous Issues
- Volume 21, Issue 2, 2025
Current Diabetes Reviews - Volume 21, Issue 2, 2025
Volume 21, Issue 2, 2025
-
-
An In-Silico Approach to Identify Therapeutic Target and Markers Associated with Diabetic Nephropathy
BackgroundRenal disease in T2DM could arise independently of hyperglycemia, aka non diabetic kidney disease. Its prevalence ranges from 33% to 72.5% among T2DM patients. Specific molecular signatures that distinguish Diabetic Nephropathy from NDKD (FSGS) in T2DM might provide new targets for CKD management.MethodsFive original GEO microarray DN and FSGS datasets were evaluated (GSE111154, GSE96804, GSE Read More
-
-
-
A Comprehensive Review on GLP-1 Signaling Pathways in the Management of Diabetes Mellitus - Focus on the Potential Role of GLP-1 Receptors Agonists and Selenium among Various Organ Systems
Authors: Ghinwa Barakat, Ghaith Assi, Hussein Khalil and Sami El KhatibDiabetes Mellitus develops when the body becomes unable to fuel its cells with glucose, which results in the accumulation of sugar excess in the bloodstream. Because it has diverse pathophysiological impacts on the body, diabetes mellitus represents a significant issue of concern in an attempt to find suitable treatment modalities and medications for afflicted diabetic patients. Glucagon-like peptide 1 (GLP-1) plays a pivo Read More
-
-
-
Exploring the Potential Benefits of Bovine Colostrum Supplementation in the Management of Diabetes and its Complications: A Comprehensive Review
Authors: Isha Chawla, Meenakshi Dhanawat, Manu Sharma and Sumeet GuptaDiabetes is a metabolic illness marked by elevated levels of glucose in the bloodstream due to the inadequate production or use of insulin in the body. Diabetes can result in a range of consequences, with the most prevalent being cardiovascular disease, renal failure, vision loss, and limb removal. Natural compounds isolated from different sources, like colostrum, are the most important compounds for the treatment of di Read More
-
-
-
Examining the Efficacy, Safety, and Future Prospects of Tirofiban in Managing Myocardial Infarction among Diabetic Patients
Authors: Haajeera Samsudeen and V.P. Dharani ShrinivasanBackgroundMyocardial infarction (MI) is a leading cause of death worldwide, particularly in patients with diabetes mellitus (DM). Tirofiban, a platelet GP IIb/IIIa receptor inhibitor, has shown promise as adjunctive therapy in the emergency management of MI in diabetic patients. However, a comprehensive understanding of its use, efficacy, safety, and limitations in this patient population is necessary to optimize treatment str Read More
-
-
-
Promising Phytoconstituents in Diabetes-related Wounds: Mechanistic Insights and Implications
Authors: Arjina Sultana, Ranadeep Borgohain, Ashwini Rayaji, Dipankar Saha and Bhrigu Kumar DasBackgroundThe onset of diabetes mellitus (DM), a metabolic disorder characterized by high blood glucose levels and disrupted glucose metabolism, results in 20% of people with diabetes suffering from diabetes-related wounds worldwide. A minor wound, such as a cut or abrasion, can lead to infections and complications in diabetic patients. We must understand the mechanism/s contributing to this delayed wound healing to de Read More
-
-
-
Pyrazole Scaffold: Potential PTP1B Inhibitors for Diabetes Treatment
Authors: Kishor R. Danao, Vijayshri V. Rokde, Deweshri M. Nandurkar and Ujwala N. MahajanBackgroundThe overexpression of the Protein Tyrosine Phosphatase 1B (PTP1B), a key role in the development of insulin resistance, diabetes (T2DM) and obesity, seems to have a substantial impact as a negative regulator of the insulin and leptin signaling pathways. Therefore, inhibiting PTP1B is a prospective therapeutic approach for the treatment of diabetes and obesity. However, the pyrazole scaffold is expected to be Read More
-
-
-
Associated Factors Influencing Quality of Life and Knowledge Among Type 2 Diabetic Patients: A Cross-Sectional Study
BackgroundThe assessment of the quality of life (QoL) among type 2 diabetic patients is associated with different factors. Evidence shows that these patients usually suffer from a lack of knowledge about the disease, inadequate self-care, and low QoL.ObjectiveThe study aimed to assess knowledge of the QoL of type 2 diabetes patients and its possible associated factors.MethodsThis cross-sectional descriptive correlation Read More
-
-
-
Early Detection of Diabetic Peripheral Neuropathy in Diabetic Patients: A Cross-Sectional Study
BackgroundDiabetic Peripheral Neuropathy (DPN) is a chronic complication in Type 2 Diabetes Mellitus (T2DM) patients and is characterized by paresthesia, pain, and hypoesthesia of the extremities. The Diabetic Neuropathy Symptom-Score (DNS) is a quick, inexpensive, and easy-to-perform tool to detect DPN in clinical practice. Biochemical markers like Nitric Oxide (NO) and Vascular Endothelial Growth Factor (VEGF) Read More
-
-
-
Prediction of Different Risk Factors in Relation to Hyperlipidemia Using Framingham Risk Score and Cholesterol Risk Score in a Tertiary Care Hospital
Authors: Abrar Ahmad Zargar, Ranjeet Kumar and Amit SharmaBackgroundA condition that affects the circulatory system of the human body is referred to as a cardiovascular disease (CVD). Cardiovascular diseases (CVDs) are responsible for a significant number of fatalities globally. Annually, CVDs result in the demise of 17.9 million people, which accounts for 31% of all fatalities on a global scale.ObjectiveThe objective of the study was to assess the demographic profile of diabetic Read More
-
-
-
Prevalence of Diabetes, Hypertension, and Obesity in Punjab: A Comparison between NFHS-4 and NFHS-5 Surveys
Authors: Amandeep Kaur, Ranjeet Kumar and Amit SharmaDiseases that are caused by a person's everyday habits are known as lifestyle diseases. Habits that devoid people of their daily activities and direct them towards a sedentary lifestyle cause numerous health problems that can lead to non-communicable diseases. Non-communicable diseases, or NCDs, kill more than 41 million individuals per year, accounting for 74% of all deaths worldwide. In India, 63% of all fatalities were attrib Read More
-
-
-
Bioinformatics to Identify Biomarkers of Diabetic Nephropathy based on Sphingolipid Metabolism and their Molecular Mechanisms
Authors: Yaxian Ning, Xiaochun Zhou, Gouqin Wang, Lili Zhang and Jianqin WangBackgroundDiabetes mellitus (DM) frequently results in Diabetic Nephropathy (DN), which has a significant negative impact on the quality of life of diabetic patients. Sphingolipid metabolism is associated with diabetes, but its relationship with DN is unclear. Therefore, screening biomarkers related to sphingolipid metabolism is crucial for treating DN.MethodsTo identify Differentially Expressed Genes (DEGs) in the GSE142153 Read More
-
Volumes & issues
-
Volume 21 (2025)
-
Volume 20 (2024)
-
Volume 19 (2023)
-
Volume 18 (2022)
-
Volume 17 (2021)
-
Volume 16 (2020)
-
Volume 15 (2019)
-
Volume 14 (2018)
-
Volume 13 (2017)
-
Volume 12 (2016)
-
Volume 11 (2015)
-
Volume 10 (2014)
-
Volume 9 (2013)
-
Volume 8 (2012)
-
Volume 7 (2011)
-
Volume 6 (2010)
-
Volume 5 (2009)
-
Volume 4 (2008)
-
Volume 3 (2007)
-
Volume 2 (2006)
-
Volume 1 (2005)
Most Read This Month
Article
content/journals/cdr
Journal
10
5
false
en
